Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Ascension and its affiliates | 899.5 | 813.3 | 794.7 | | | | | |
| Ascension | | | | 599.3 | 404.8 | | | |
| Intermountain Healthcare | 206.4 | 177.9 | 177.9 | 121.6 | 18.0 | | | |
| Other | 368.7 | 279.6 | 213.5 | 147.6 | 27.0 | | | |
| Total revenues [+] | 1,474.6 | 1,270.8 | 1,186.1 | 868.5 | 449.8 | 899.9 | 117.2 | 210.1 |
| Services | 1,474.6 | 1,270.8 | 1,186.1 | 868.5 | | | 117.2 | 210.1 |
| Revenue growth [+] | 16.0% | 7.1% | 36.6% | 93.1% | -50.0% | 667.8% | -44.2% | -58.4% |
| Ascension and its affiliates | 10.6% | 2.3% | | | | | | |
| Ascension | | | | 48.0% | | | | |
| Intermountain Healthcare | 16.0% | 0.0% | 46.3% | 575.8% | | | | |
| Cost of goods sold | 1,162.8 | 1,021.1 | 987.8 | 770.6 | 416.3 | 199.7 | 169.0 | 182.1 |
| Gross profit | 311.8 | 249.7 | 198.3 | 97.9 | 33.5 | 700.2 | -51.8 | 28.0 |
| Gross margin | 21.1% | 19.6% | 16.7% | 11.3% | 7.4% | 77.8% | -44.2% | 13.3% |
| Selling, general and administrative | 120.0 | 102.4 | 104.4 | 97.9 | 56.3 | 74.1 | 75.0 | 69.9 |
| Other operating expenses | 46.1 | 67.3 | 36.2 | 30.4 | 4.7 | 315.5 | -0.1 | |
| EBITDA [+] | 223.2 | 148.7 | 113.4 | 8.4 | -11.2 | 320.8 | -118.2 | -35.8 |
| EBITDA growth | 50.1% | 31.1% | 1250.0% | -175.0% | -103.5% | -371.4% | 229.8% | -114.6% |
| EBITDA margin | 15.1% | 11.7% | 9.6% | 1.0% | -2.5% | 35.6% | -100.9% | -17.1% |
| Depreciation | 54.6 | 50.6 | 55.7 | 38.8 | 16.3 | 10.2 | 8.5 | 6.0 |
| EBITA | 168.6 | 98.1 | 57.7 | -30.4 | -27.5 | 310.6 | -126.7 | -41.9 |
| EBITA margin | 11.4% | 7.7% | 4.9% | -3.5% | -6.1% | 34.5% | -108.1% | -19.9% |
| Amortization of intangibles | 22.9 | 18.1 | | | | | | |
| EBIT [+] | 145.7 | 80.0 | 57.7 | -30.4 | -27.5 | 310.6 | -126.7 | -41.9 |
| EBIT growth | 82.1% | 38.6% | -289.8% | 10.5% | -108.9% | -345.1% | 202.5% | -117.6% |
| EBIT margin | 9.9% | 6.3% | 4.9% | -3.5% | -6.1% | 34.5% | -108.1% | -19.9% |
| Non-recurring items [+] | | | | | | 12.7 | 9.3 | 86.8 |
| Unusual expense | | | | | | | 9.3 | 86.8 |
| Interest expense, net [+] | 18.9 | 17.3 | 29.1 | 26.3 | 0.2 | -0.3 | -0.2 | -0.3 |
| Interest expense | 18.9 | 17.3 | 29.1 | 26.3 | 0.2 | | | |
| Interest income | | | | | | 0.3 | 0.2 | 0.3 |
| Other income (expense), net [+] | | 55.7 | -18.8 | | 0.4 | | | |
| Gain (loss) on sale of business | | 55.7 | | | | | | |
| Gain (loss) on debt retirement | | | -18.8 | | | | | |
| Pre-tax income | 126.8 | 118.4 | 9.8 | -56.7 | -27.3 | 298.2 | -135.8 | -128.4 |
| Income taxes | 29.6 | 1.3 | -2.2 | -11.4 | 31.5 | 121.1 | -51.6 | -48.7 |
| Tax rate | 23.3% | 1.1% | | 20.1% | | 40.6% | 38.0% | 38.0% |
| Net income | -495.1 | 57.0 | -8.7 | -64.4 | -76.5 | 65.4 | -84.3 | -79.6 |
| Net margin | -33.6% | 4.5% | -0.7% | -7.4% | -17.0% | 7.3% | -71.9% | -37.9% |
| |
| Basic EPS [+] | ($1.86) | $0.49 | ($0.08) | ($0.60) | ($0.75) | $0.65 | ($0.87) | ($0.83) |
| Growth | -477.6% | -731.3% | -86.9% | -20.6% | -214.8% | -175.0% | 4.7% | -161.2% |
| Diluted EPS [+] | ($1.86) | $0.33 | ($0.08) | ($0.60) | ($0.75) | $0.65 | ($0.87) | ($0.83) |
| Growth | -669.7% | -518.5% | -86.9% | -20.6% | -214.8% | -175.0% | 4.7% | -161.9% |
| |
| |
| Shares outstanding (basic) [+] | 266.2 | 115.7 | 111.5 | 108.2 | 102.1 | 100.2 | 96.8 | 95.8 |
| Growth | 130.0% | 3.8% | 3.1% | 6.0% | 1.9% | 3.5% | 1.1% | 0.1% |
| Shares outstanding (diluted) [+] | 266.2 | 174.6 | 111.5 | 108.2 | 102.1 | 100.2 | 96.8 | 95.8 |
| Growth | 52.5% | 56.6% | 3.1% | 6.0% | 1.9% | 3.5% | 1.1% | -1.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|